newsfilter
← Latest News
PR Newswire·

Nuvalent Announces Pricing of Public Offering of Common Stock

Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven...